Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Lamarca

Showing results (91-100 of 201) with videos related to

Pageof 21
Sort By:
Cancers|February 25, 2022
Molecular Profiling of Well-Differentiated Neuroendocrine Tumours: The Role of ctDNA in Real-World PracticeAngela Lamarca, Melissa Frizziero, Jorge Barriuso, et al.
ESMO Open|March 20, 2020
Safety, tolerability and clinical implementation of 'ready-to-use' <sup>68</sup>gallium-DOTA0-Tyr3-octreotide (<sup>68</sup>Ga-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs)Prakash Manoharan, Angela Lamarca, Shaunak Navalkissoor, et al.
Journal of Hepatology|February 24, 2019
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography (<sup>18</sup>FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysisAngela Lamarca, Jorge Barriuso, Amarjot Chander, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2022
Clinical challenges associated with utility of neoadjuvant treatment in patients with pancreatic ductal adenocarcinomaSimon Gray, Nicola de Liguori Carino, Ganesh Radhakrishna, et al.
Neuroendocrinology|April 12, 2017
68Gallium DOTANOC-PET Imaging in Lung Carcinoids: Impact on Patients' ManagementAngela Lamarca, D Mark Pritchard, Thomas Westwood, et al.
Current Treatment Options in Oncology|June 29, 2021
Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine TumoursMohammed Dawod, Teresa Alonso Gordoa, Mauro Cives, et al.
Cancers|December 10, 2020
Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer PatientsPatricia García, Angela Lamarca, Javier Díaz, et al.
Plos One|November 28, 2019
Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancerMarc Abraham, Zoe Kordatou, Jorge Barriuso, et al.
The Oncologist|May 31, 2022
Everolimus-Induced Pneumonitis in Patients with Neuroendocrine Neoplasms: Real-World Study on Risk Factors and OutcomesRodrigo G Taboada, Rachel P Riechelmann, Carine Mauro, et al.
Journal of Neuroendocrinology|June 30, 2026
Controversies in NEN: An ENETS position statement on the interchangeability of somatostatin receptor PET tracersChristophe M Deroose, Valentina Ambrosini, Johanes Hofland, et al.
Pageof 21

Showing results (91-100 of 201) with videos related to

Sort By:
Pageof 21
Cancers|February 25, 2022
Molecular Profiling of Well-Differentiated Neuroendocrine Tumours: The Role of ctDNA in Real-World PracticeAngela Lamarca, Melissa Frizziero, Jorge Barriuso, et al.
ESMO Open|March 20, 2020
Safety, tolerability and clinical implementation of 'ready-to-use' <sup>68</sup>gallium-DOTA0-Tyr3-octreotide (<sup>68</sup>Ga-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs)Prakash Manoharan, Angela Lamarca, Shaunak Navalkissoor, et al.
Journal of Hepatology|February 24, 2019
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography (<sup>18</sup>FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysisAngela Lamarca, Jorge Barriuso, Amarjot Chander, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2022
Clinical challenges associated with utility of neoadjuvant treatment in patients with pancreatic ductal adenocarcinomaSimon Gray, Nicola de Liguori Carino, Ganesh Radhakrishna, et al.
Neuroendocrinology|April 12, 2017
68Gallium DOTANOC-PET Imaging in Lung Carcinoids: Impact on Patients' ManagementAngela Lamarca, D Mark Pritchard, Thomas Westwood, et al.
Current Treatment Options in Oncology|June 29, 2021
Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine TumoursMohammed Dawod, Teresa Alonso Gordoa, Mauro Cives, et al.
Cancers|December 10, 2020
Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer PatientsPatricia García, Angela Lamarca, Javier Díaz, et al.
Plos One|November 28, 2019
Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancerMarc Abraham, Zoe Kordatou, Jorge Barriuso, et al.
The Oncologist|May 31, 2022
Everolimus-Induced Pneumonitis in Patients with Neuroendocrine Neoplasms: Real-World Study on Risk Factors and OutcomesRodrigo G Taboada, Rachel P Riechelmann, Carine Mauro, et al.
Journal of Neuroendocrinology|June 30, 2026
Controversies in NEN: An ENETS position statement on the interchangeability of somatostatin receptor PET tracersChristophe M Deroose, Valentina Ambrosini, Johanes Hofland, et al.
Pageof 21